MYTERA 250 TABLET contains Abiraterone which belongs to a group of medicines called Androgen biosynthesis inhibitors. MYTERA 250 TABLET is used with prednisone/prednisolone in adult men to treat prostate cancer that has spread to other parts of the body.
MYTERA 250 TABLET is also to treat early stage of prostate cancer when used with androgen deprivation therapy (treatment that lowers testosterone hormone) and prednisone/prednisolone (medication) in affected individuals.
MYTERA 250 TABLET is not recommended for use in patients allergic to abiraterone. It is also not recommended for use in patients suffering from severe liver disease.
Before taking MYTERA 250 TABLET, inform your doctor if you have high blood pressure, any other blood vessel problems (such as blood pressure, stroke), swelling in the feet/ankles/legs, diabetes, lung problems (such as shortness of breath), heart problems (such as heart failure, irregular/rapid heart rate), kidney, and/or liver problems.
MYTERA 250 TABLET is not recommended for use in pregnant and breastfeeding women since it is intended to be used only in male patients.
MYTERA 250 TABLET is also not recommended for use in children and adolescents (aged below 18 years) and is advised to be used with caution in elderly patients (aged 75 years/above) after consulting the doctor.
The most common side effects of taking MYTERA 250 TABLET are swelling in legs/feet, high blood pressure, urinary tract infection, diarrhea, indigestion, chest pain, irregular heartbeat, and/or rash. Contact your doctor if any of the symptoms worsen.